Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wen-Yu Lin

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
ESC Heart Failure|January 7, 2021
Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fractionYing-Hsiang Lee, Po-Lin Lin, Wei-Ru Chiou, et al.
Journal of the Chinese Medical Association : JCMA|September 15, 2021
Treatment with angiotensin receptor neprilysin inhibitor for Taiwan heart failure patients: Rationale and baseline characteristics of the TAROT-HF studyWen-Yu Lin, Fa-Po Chung, Chia-Te Liao, et al.
Acta Cardiologica Sinica|April 29, 2016
Activation of Krüppel-Like Factor 2 with Ginkgo Biloba Extract Induces eNOS Expression and Increases NO Production in Cultured Human Umbilical Endothelial CellsTsung-Neng Tsai, Wei-Shing Lin, Chun-Hsien Wu, et al.
ESC Heart Failure|July 30, 2021
The association between ivabradine and adverse cardiovascular events in acute decompensated HFrEF patientsChia-Te Liao, Jin-Long Huang, Huai-Wen Liang, et al.
BMC Endocrine Disorders|August 17, 2013
The association of anthropometry indices with gout in Taiwanese menWen-Yu Lin, Chia-Chi Lung, Ting-Sung Liu, et al.
Journal of the Chinese Medical Association : JCMA|April 26, 2021
The evolution of guideline-directed medical therapy among decompensated HFrEF patients in sacubitril/valsartan era: Medical expenses and clinical effectivenessHuai-Wen Liang, Chia-Te Liao, Wen-Yu Lin, et al.
Frontiers in Cardiovascular Medicine|August 12, 2022
Utility of PREDICT-HF score in high-risk Asian heart failure patients receiving sacubitril/valsartanChien-Yi Hsu, Hung-Yu Chang, Chieh-Ju Chao, et al.
ESC Heart Failure|August 10, 2022
Clinical impacts of sacubitril/valsartan on patients eligible for cardiac resynchronization therapyHsin-Ti Huang, Jin-Long Huang, Po-Lin Lin, et al.
Medicina (Kaunas, Lithuania)|January 21, 2023
Takotsubo Syndrome Occurring after mRNA COVID-19 Vaccination in a Patient with Graves' DiseaseYen-Chi Chen, Gen-Min Lin, Eiki Takimoto, et al.
Heart Rhythm|February 3, 2015
Resveratrol, a red wine antioxidant, reduces atrial fibrillation susceptibility in the failing heart by PI3K/AKT/eNOS signaling pathway activationEric Chong, Shih-Lin Chang, Ya-Wen Hsiao, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
ESC Heart Failure|January 7, 2021
Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fractionYing-Hsiang Lee, Po-Lin Lin, Wei-Ru Chiou, et al.
Journal of the Chinese Medical Association : JCMA|September 15, 2021
Treatment with angiotensin receptor neprilysin inhibitor for Taiwan heart failure patients: Rationale and baseline characteristics of the TAROT-HF studyWen-Yu Lin, Fa-Po Chung, Chia-Te Liao, et al.
Acta Cardiologica Sinica|April 29, 2016
Activation of Krüppel-Like Factor 2 with Ginkgo Biloba Extract Induces eNOS Expression and Increases NO Production in Cultured Human Umbilical Endothelial CellsTsung-Neng Tsai, Wei-Shing Lin, Chun-Hsien Wu, et al.
ESC Heart Failure|July 30, 2021
The association between ivabradine and adverse cardiovascular events in acute decompensated HFrEF patientsChia-Te Liao, Jin-Long Huang, Huai-Wen Liang, et al.
BMC Endocrine Disorders|August 17, 2013
The association of anthropometry indices with gout in Taiwanese menWen-Yu Lin, Chia-Chi Lung, Ting-Sung Liu, et al.
Journal of the Chinese Medical Association : JCMA|April 26, 2021
The evolution of guideline-directed medical therapy among decompensated HFrEF patients in sacubitril/valsartan era: Medical expenses and clinical effectivenessHuai-Wen Liang, Chia-Te Liao, Wen-Yu Lin, et al.
Frontiers in Cardiovascular Medicine|August 12, 2022
Utility of PREDICT-HF score in high-risk Asian heart failure patients receiving sacubitril/valsartanChien-Yi Hsu, Hung-Yu Chang, Chieh-Ju Chao, et al.
ESC Heart Failure|August 10, 2022
Clinical impacts of sacubitril/valsartan on patients eligible for cardiac resynchronization therapyHsin-Ti Huang, Jin-Long Huang, Po-Lin Lin, et al.
Medicina (Kaunas, Lithuania)|January 21, 2023
Takotsubo Syndrome Occurring after mRNA COVID-19 Vaccination in a Patient with Graves' DiseaseYen-Chi Chen, Gen-Min Lin, Eiki Takimoto, et al.
Heart Rhythm|February 3, 2015
Resveratrol, a red wine antioxidant, reduces atrial fibrillation susceptibility in the failing heart by PI3K/AKT/eNOS signaling pathway activationEric Chong, Shih-Lin Chang, Ya-Wen Hsiao, et al.
Pageof 9